V-Bio Ventures finds, builds and finances young, innovative companies with ambitions in the life sciences arena.Our fund, established in 2015, works closely with Belgium-based VIB, one of the world’s premier life science institutes. We invest throughout Europe in start-up and early-stage companies with high growth potential. These are drawn from both VIB’s own research pipeline and elsewhere. We focus on technologies that provide transformational improvements in the biopharmaceutical, pharmaceutical, diagnostics and agricultural sectors.Our extensive network and expertise in the sector allow us to contribute more than just capital. We aim at being part of the DNA of the new ventures that we back.
Latest newsMore news
Mithra announces topline results for COVID-19 Phase II Study
1 day ago
Biocartis announces restart of its high-throughput cartridge manufacturing line
Thursday September 23rd 2021
Rewind Therapeutics appoints Anja Harmeier, PhD, MBA, as Chief Executive Officer
Wednesday September 22nd 2021